Similar articles for PMID: 29115660

Year	Number of Results
1986	1
1989	1
1990	1
1999	1
2001	3
2002	3
2003	2
2004	5
2005	6
2006	4
2007	4
2008	4
2009	11
2010	24
2011	19
2012	9
2013	22
2014	33
2015	24
2016	23
2017	27
2018	41
2019	58
2020	61
2021	55
2022	21
2023	3

1

Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.

Zhou JD, Zhang TJ, Li XX, Ma JC, Guo H, Wen XM, Yao DM, Zhang W, Lin J, Qian J. Zhou JD, et al. J Cell Physiol. 2018 Jun;233(6):4707-4714. doi: 10.1002/jcp.26253. Epub 2018 Jan 15. J Cell Physiol. 2018. PMID: 29115660

2

CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.

Gao L, Liu F, Zhang H, Sun J, Ma Y. Gao L, et al. Genes Chromosomes Cancer. 2016 Feb;55(2):158-68. doi: 10.1002/gcc.22322. Epub 2015 Nov 6. Genes Chromosomes Cancer. 2016. PMID: 26542416

3

Methylation of gene CHFR promoter in acute leukemia cells.

Gong H, Liu W, Zhou J, Xu H. Gong H, et al. J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):240-2. doi: 10.1007/BF02828130. J Huazhong Univ Sci Technolog Med Sci. 2005. PMID: 16201259

4

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T. Baba S, et al. Oncol Rep. 2009 Nov;22(5):1173-9. doi: 10.3892/or_00000552. Oncol Rep. 2009. PMID: 19787237 Free article.

5

Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.

Cha Y, Kim SY, Yeo HY, Baek JY, Choi MK, Jung KH, Dong SM, Chang HJ. Cha Y, et al. Neoplasia. 2019 Jan;21(1):146-155. doi: 10.1016/j.neo.2018.11.010. Epub 2018 Dec 15. Neoplasia. 2019. PMID: 30562637 Free PMC article.

6

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.

Sun GK, Tang LJ, Zhou JD, Xu ZJ, Yang L, Yuan Q, Ma JC, Liu XH, Lin J, Qian J, Yao DM. Sun GK, et al. Cancer Med. 2019 Oct;8(14):6393-6402. doi: 10.1002/cam4.2540. Epub 2019 Sep 4. Cancer Med. 2019. PMID: 31486300 Free PMC article.

7

CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer.

Hagiwara T, Sugimoto K, Momose H, Irie T, Honjo K, Okazawa YU, Kawai M, Kawano S, Munakata S, Takahashi M, Kojima Y, Serizawa N, Nagahara A, Hoffman RM, Brock MV, Sakamoto K. Hagiwara T, et al. Anticancer Res. 2022 Feb;42(2):697-707. doi: 10.21873/anticanres.15528. Anticancer Res. 2022. PMID: 35093868

8

Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.

Zhang ZH, Zhang W, Zhou JD, Zhang TJ, Ma JC, Xu ZJ, Lian XY, Wu DH, Wen XM, Deng ZQ, Lin J, Qian J. Zhang ZH, et al. Mol Carcinog. 2018 Jun;57(6):735-744. doi: 10.1002/mc.22794. Epub 2018 Mar 6. Mol Carcinog. 2018. PMID: 29457658

9

Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia.

Nan FY, Gu Y, Xu ZJ, Sun GK, Zhou JD, Zhang TJ, Ma JC, Leng JY, Lin J, Qian J. Nan FY, et al. Cancer Med. 2021 Aug;10(15):5283-5296. doi: 10.1002/cam4.4085. Epub 2021 Jul 5. Cancer Med. 2021. PMID: 34227248 Free PMC article.

10

Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.

Lian XY, Ma JC, Zhou JD, Zhang TJ, Wu DH, Deng ZQ, Zhang ZH, Li XX, He PF, Yan Y, Lin J, Qian J. Lian XY, et al. J Cell Physiol. 2019 Jun;234(6):9438-9446. doi: 10.1002/jcp.27629. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed